Axsome Therapeutics Inc’s recent filing unveils that its Chief Financial Officer Pizzie Nick unloaded Company’s shares for reported $1.56 million on Feb 13 ’25. In the deal valued at $129.86 per share,12,000 shares were sold. As a result of this transaction, Pizzie Nick now holds 42,187 shares worth roughly $4.46 million.
Then, Pizzie Nick sold 3,000 shares, generating $393,210 in total proceeds. Upon selling the shares at $131.07, the Chief Financial Officer now owns 42,187 shares.
Before that, Pizzie Nick bought 3,000 shares. Axsome Therapeutics Inc shares valued at $393,202 were divested by the Officer at a price of $131.07 per share.
Jefferies initiated its Axsome Therapeutics Inc [AXSM] rating to a Buy in a research note published on April 07, 2025; the price target was $200. A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who began to cover the stock in mid February with a ‘”a Buy”‘ rating. Mizuho also remained covering AXSM and reiterated its “an Outperform” recommendation on December 31, 2024. Wells Fargo started covering the stock on September 03, 2024. It rated AXSM as “an Overweight”.
Price Performance Review of AXSM
On Tuesday, Axsome Therapeutics Inc [NASDAQ:AXSM] saw its stock fall -4.08% to $105.67. Over the last five days, the stock has lost -5.79%. Axsome Therapeutics Inc shares have risen nearly 24.89% since the year began. Nevertheless, the stocks have risen 43.42% over the past one year. While a 52-week high of $139.13 was reached on 02/21/25, a 52-week low of $64.11 was recorded on 01/10/25. SMA at 50 days reached $112.76, while 200 days put it at $99.97.
Levels Of Support And Resistance For AXSM Stock
The 24-hour chart illustrates a support level at 103.83, which if violated will result in even more drops to 101.99. On the upside, there is a resistance level at 108.89. A further resistance level may holdings at 112.12. The Relative Strength Index (RSI) on the 14-day chart is 43.48, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.96, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 85.04%. Stochastics %K at 28.67% indicates the stock is a holding.
